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Abstract
  
 Eleutherine palmifolia (L.) Merr. is a typical plant found in Central Kalimantan that 
has been used empirically by the Dayak people as medicine for various diseases, including 
cancer. The plant contains flavonoid compounds that potentially used as an anticancer. 
The purpose of this study is to find the most active fraction, indicated by its cytotoxic 
potency on HeLa cervical cancer cell line, and to identify compounds in E. palmifolia 
bulbs fraction. E. palmifolia bulbs was extracted by maceration. The extraction with 
ultrasonic bath and partition fractionation was conducted by using n-hexane, chloroform, 
and ethyl acetate. Each fraction was tested for toxicity level on HeLa cells using MTT 
assay. The identification of active compounds was carried out by Ultra Performance 
Liquid Chromatography-Mass Spectrometry (UPLC-MS). The result showed that based 
on the IC50 value, the ethyl acetate fraction had the highest bioactivity. IC50 values of 
n-hexane, chloroform, and ethyl acetate fractions were 250.77±19.01; 720.46±42.38; and 
44.34±9.45µg/mL, respectively. The identification of the active compound in ethyl acetate 
fraction resulted 28 chemical compounds. Compounds with the highest percentage area 
were isoliquiritigenin and oxyresveratrol. The ethyl acetate fraction of E. palmifolia 
bulbs is potential to be developed as an anticancer candidate (phytopharmaceutical).
Keywords: Compound identification, Anticancer activity, Eleutherine palmifolia (L.) 
Merr., cervical cancer
INTRODUCTION
  Cervical cancer is the second most common 
type of cancer among women after breast cancer 
and the third largest cause of death due to cancer in 
women. World Health Organization or WHO states 
that every year, more than 270,000 women died of 
cervical cancer, and more than 85% of these deaths 
occur in developing countries. Indonesia is the sixth 
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of 50 countries in the world with the highest deaths 
from cervical cancer which is 7,493 (WHO, 2013).
 Eleutherine palmifolia (L.) Merr. (“bawang 
sabrang” in Indonesian) is a typical plant found in 
Central Kalimantan that has been used empirically 
by the Dayak people as medicine for various types 
of diseases such as cancer, hypertension, and diabe-
tes. It can also be used to lower cholesterol, prevent 
ulcers as well as stroke, and reduce stomach pain 
after childbirth (Galingging, 2009). E. palmifolia 
bulbs contain bioactive compounds with antican-
cer effects. One of the bioactive compounds is fla-
vonoid. Flavonoids are compounds proven to inhibit 
cancer cell proliferation (Mardiyaningsih, 2014). 
Inhibition of cervical cancer cells occurs in the path 
of estrogen/Er-α so that it can suppress cell prolif-
eration on cervical cancer (Chung, et al., 2010).
 E. palmifolia has been discussed in many 
anticancer studies. The ethanol extract of  E. 
palmifolia has a cytotoxic effect on HT29 colon 
carcinoma with LC50 of 3.125 mg/mL, and the 
p53 mutant can be suppressed by triterpenoid, fla-
vonoid, anthraquinone, and coumarin compounds 
(Yusni, 2009). Ethanolic extract of E. palmifolia 
can inhibit the growth of cervical cancer HeLa cell 
with IC50 of 40.36 µg/mL (Mutiah, et al., 2017).
 Ultra-Performance Liquid Chromatog-
raphy-Mass Spectrometry (UPLC-MS) is the de-
velopment of LC-MS techniques which can be 
utilized to analyze compound. The method of 
chromatography can present reliable, high resolu-
tion of the chromatogram, accurate measurement 
of mass, and structural information as well as to 
detect a large number of metabolites in a sample 
of plants (Kumar, et al., 2014). UPLC that is ap-
plied with MS is developed to be a powerful in-
strument to simultaneously identify and quantify 
chemical compounds contained in the raw materi-
als of traditional medicines (Zao & Lin, 2014).
 This study aims to determine the an-
ticancer activity of E. palmifolia bulb fraction 
on HeLa cervical cancer cell line and to ana-
lyze compounds of the most active fraction.
MATERIALS AND METHODS
Materials
 The materials used in this study, E. palmi-
folia bulbs, were taken from Materia Medica 
Batu, Malang, Indonesia. Determination of the 
plant was done at the Indonesian Institute of Sci-
ences with a reference number of 0065/IPH.6/
HM/I/2017. HeLa cells were obtained from the 
collection of Parasitology Laboratory, Faculty of 
Medicine, Public Health and Nursing, Universi-
tas Gadjah Mada (UGM). Other materials were 
phosphate buffer saline (PBS) (Merck, Darm-
stadt, Germany), trypsin EDTA (Gibco, Invitrogen
cell culture, Carisbad, USA), fetal bovine serum 
(FBS) (Gibco), penicillin-streptomycin (Gibco), 
Fungizone (Gibco), culture medium DMEM (Sig-
ma-Aldrich, St Louis USA), DMSO (Sigma), 5 
mg/mL MTT (Sigma) in PBS, 10% SDS in 0,1 
N HCl (Merck), 96% ethanol (Sigma) aquadest, 
n-hexane (Sigma), chloroform (Sigma), and ethyl 
acetate (Sigma). The instrument used in this re-
search were moisture analyzer (Mettler Toledo, 
Bekasi, Indonesia), a rotary evaporator (IKA, 
Ohio, USA), 96-well plate (Nunclon, Denmark), 
ELISA reader (Bio-Rad, Jakarta, Indonesia), and 
Ultra Performance Liquid Chromatography-Qua-
drupole Time of Flight-Mass Spectrometry (UP-
LC-QtoF-MS) (Waters, Massachusetts, USA).
Extraction
 E. palmifolia bulbs were washed clean, 
cut into small pieces, dried-puree, powdered us-
ing a blender and sifted. The powder was ex-
tracted using 96% ethanol solvent with ultrasonic 
bath for ±18 minutes (min). The filtrate was then 
collected and evaporated using a rotary evap-
orator. Multilevel fractionation was then per-
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formed using n-hexane, chloroform, and ethyl 
acetate solvent with a 1:1 solvent ratio. It was 
then concentrated and used as a test sample.
Cytotoxicity test using MTT assay
 Cervical cancer HeLa cells were suspended 
in the culture medium (DMEM supplemented with 
FBS and penicillin-streptomycin) to reach 1.5x106 
cells/mL. Cells (104 cells/100 µL) were implanted 
into 96-well plates and then incubated for 24 h. A 
total of 1 mg of the fraction (n-hexane, chloroform, 
ethyl acetate) was dissolved in 100 µL of dimethyl 
sulfoxide (DMSO). The solution was used as a 
stock. Furthermore, the fraction was made with a 
series of doses: 125; 62.5; 31.25; 15,625; 7,8125; 
and 3.90625 μg/mL. Cisplatin concentration series 
that are 100; 50; 25; 12.5; 6.25; 3,125; and 1.5625 
µg/mL was used as positive control. After 24 h of 
incubation, the cells were observed and prepared for 
treatment using a test solution, which is n-hexane 
fraction, chloroform fraction, ethyl acetate fraction, 
and cisplatin. Each concentration was repeated in 
triplicate. Determination of anticancer activity was 
performed in vitro using MTT assay. MTT method 
is a colorimetric method based on the change of 
tetrazolium salt [3-(4,5-dimetiltiazol-2-yl)-2,5-dif-
eniltetrazolium bromide] (MTT) into formazan 
in the mitochondria that are active in living cells 
(Doyle & Griffiths, 2000). The cells were there 
re-incubated for 24 h. At the end of incubation, 100 
µL of MTT reagent solution was added to the wells. 
The plate incubated for 4 hours to form formazan 
crystals. The number of formazan crystals formed 
correlates with cell viability. After 4 h incubation, 
the reaction of MTT was halted by the addition of 
stopper reagent sodium dodecyl sulfate (SDS) then 
the plate was incubated for another 24 h at room 
temperature. The measurement of absorbance was 
conducted using ELISA reader. Data obtained in the 
form of absorbance were subsequently converted to 
percentage of cell viability (Mutiah, 2014). The IC50 
value was calculated using SPSS probit analysis.
Identification of active compound 
 Determination of active compound can be 
carried out by a chromatographic technique such as 
UPLC-QtoF-MS. This technique can be combined 
with bioassay cytotoxic test profiling and correlated 
with multivariate statistical analysis. This technique 
is faster and more efficient in the business discov-
ery of new compounds (Wolfender, et al., 2015). 
The active compounds of the most-active fraction 
were identified using ACQUITY UPLC HSS C18 
column in tandem with MS tandem quadrupole sys-
tem, ESI positive ion mode. The motion phase was 
a mixture of 0.1% formic acid in water and 0.1% 
formic acid in acetonitrile. The source temperature 
was 100°C, and the desolvation temperature was 
350°C. A 10 mg extract sample was solved in 10 
mL volumetric flask with absolute methanol then 5 
µL volume was injected into the UPLC-MS system. 
From chromatogram data, the area was presented in 
percentage. The chromatogram was processed us-
ing Masslynx version 4.1 software (Waters, Massa-
chusetts, USA). The component identification was 
based on the ratio of measured m/z in Masslynx and 
ChemDraw version 12.0 (CambridgeSoft, Cam-
bridge, USA).
RESULTS
Cytotoxicity test
 Extracts were tested for the in vitro anti-
cancer activity on HeLa cell line. The IC50 values 
were 250.77±19.01; 720.46±42.38, and 44.34±9.45 
µg/mL for n-hexane, chloroform, and ethyl acetate 
fractions, respectively. The most active fraction was 
ethyl acetate. Table 1 showed the IC50 values from 
each fraction.
Identification of active compounds 
 The compound of ethyl acetate fraction was 
analyzed using UPLC-MS. Identification of the ac-
tive compound was done using MassLynk software 
version 4.1 and compared to a database (ChemSpi-
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der, ChemDraw). The results of the chromatogram 
sample are shown in Figure 1. 
 Each chromatogram peak indicated one 
compound. The application of Masslynx 4.1 was 
used to process the chromatogram to find out the 
m/z spectrum. Therefore, the molecule formula of 
the interpretation product compound could pre-
dict. Then, the ChemSpider website helped the 
researcher to find out the compound name of the 
prediction. By integrating and linking compounds 
from hundred of data sources, the whole molecule 
should be taken away by one atom. After finding the 
name of the compound and structure, the measured 
and calculated m/z were compared by drawing the 
compound structure using ChemDraw Ultra 12.0 
(Skoog, et al., 2004). If the difference is ≤0.0005, 
then the peak belonged to the predicted compound 
(Brenton & Godfrey, 2010). From data interpreta-
tion, 38 compounds were revealed that consisted of 
19 known structural formula and 9 unknown struc-
tures. The obtained active compounds, molecular 
formulas, and compound structures are shown in 
Table 2. The data interpretation showed that 2 com-
pounds had the highest concentration in the sample, 
which are isoliquiritigenin (retention time of 8.629; 
structural formula of C15H11O4) and oxyresver-
atrol (retention time of 6.291; structural formula of 
C14H12O4). The mass spectra and the structural for-
mula of those two compounds is shown in Figures 
2 and 3.
Table 1. IC50 Values of Each Fraction
*Average ± standard deviation, triplicate for each experiment
Figure 1. UPLC-MS chromatogram of Ethyl Acetate Fraction from Eleutherine palmifolia (L.) Merr. Bulb
Fraction 
Average of % viability HeLa  cells (µg/mL) ± SD* 
IC50  ± SD * (µg/mL)
125 62.5 3 1.25 1 5.63 7 .81 3.91  
N-hexane 30.29±3.40 1 6.07±0.72 5.78± 1.59 2.31± 0.69 28.90±1.06 8 4.05±5.25 250.77±19.01 
Chloroform 37.57±5.56 1 8.61±3.67 18.26±3.34 1 4.45±0.60 15.72±1.64 1 8.27±2.11 720.46±42.38 
Ethyl acetate 32.95±2.69 2 9.83±9.65 51.79±8.33 8 0.12±4.34 99.92±0.13 9 7.61±4.14 44.34±9.45
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Table 2. The Active Compounds and Molecular Formula
Rt (min) Measure M/Z 
Calculated 
M/Z % Area 
Formula 
Structural Formula 
Compounds Name 
1.352 103.0997 103.0997 0.0544 
C5H13NO 
 
L-(+)-Valinol 
 
 
 
1.535 290.0791 290.079 0.6879 
C15H14O6 
 
D-(+)-Catechin 
 
 
 
 
 
 
2.301 
 
 
 
123.0321 123.032 0.1567 
C6H5NO2 
 
Isonicotinic acid 
 
 
 
 
 
 
 
2.552 267.2495 267.2495 0.0471 
C11H9N9 N-(1H-Benzotriazol-
1-ylmethyl)tetrazolo[1,5-
b]pyridazin-6-amine 
3.764 290.075 290.075 0.0082 
C10H14N2O8  
 
 
N,N -(1S,2S)-1,2-
Cyclohexanediylbis(imidodic
arbonic acid) 
 
 
 
4.382 290.0791 290.079 0.1417 
C15H14O6 
 
D-(+)-Catechin  
 
 
4.679 290.0804 290.0804 0.8771 
C16H10N4O2 
 
3-(2-Pyridyl)-5,6-bis(2-
furyl)-1,2,4-triazine 
 
 
5.891 419.1355 - 14.6482 
C22H18N4O5 
 
UNKNOWN 
UNKNOWN 
N
N
N
N
N
N
H
N
NN
NH2
HO
OH
OH
HO O
OH
OH
N
O
OH
O
HO
N
O
OH
O OH
OH
OH
HO O
OH
OH
N
N
N
O
O
N
 136
Indonesian Journal of Cancer Chemoprevention, October 2019
ISSN: 2088–0197
e-ISSN: 2355-8989
Rt (min) Measure M/Z 
Calculated 
M/Z % Area 
Formula 
Structural Formula 
Compounds Name 
8.738 680.2105 6 80.2105 5.2187 
C35H36O14 
 
-
d]-1,3-dioxol-6(5aH)-one, 
5,8,8a,9-tetrahydro-5-(4-
hydroxy-3,5-
dimethoxyphenyl)-9-[[4,6-O-
[(4-
methoxyphenyl)methylene]h
exopyranosyl]oxy]- 
 
 
9.001 725.2082 -  1 .7712 
C36H36O16 
 
UNKNOWN 
UNKNOWN 
9.435 392.1247 3 92.1246 0.0881 
C20H12N10 
 
-[Benzene-1,4-dyl-
di(ethyne-2,1-
diyl)]diadenine 
 
 
9.801 244.0736 2 44.0736 1.7966 
C14H12O4 
 
Oxyresveratrol /  
4-[(E)-2-(3,5-
Dihydroxyphenyl)vinyl]-1,3-
benzenediol 
 
 
10.053 2 59.0984 - 0.4578 
C16H10N4 
 
UNKNOWN 
UNKNOWN 
10.533 3 59.0767 - 2.0586 
C18H14O8 
 
UNKNOWN 
UNKNOWN 
11.333 2 44.0736 244.0736 9 .9249 
C14H12O4 
 
Oxyresveratrol /  
4-[(E)-2-(3,5-
Dihydroxyphenyl)vinyl]-1,3-
benzenediol 
 
 
14.855 3 00.1335 300.1335 0 .484 
C14H16N6O2 
 
1-(4,6-dimethylpyrimidin-2-
yl)-3-(4-methyl-3-
nitrophenyl)guanidine 
 
 
O
O
O
O
O
OH
OH
O
O
O
O
OO
OH
N
N
NH2
N
H
N
N
N
NH2
N
H
N
HOO H
OH
OH
HOO H
OH
OH
N
H
N
H
NH
N+
O
-O
N
N
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Figure 2. Mass Spectra and Structure Formula of Isoliquiritigenin
HOO H
OH
OH
Major Active Compound (2)
Figure 3. Mass Spectra and Structure Formula of Oxyresveratrol
DISCUSSION
 This study aims to determine the cytotoxic 
of onion extracts and fractions of E. palmifolia and 
to determine the active compounds, which has the 
highest anticancer activity. The cytotoxic level of 
the sample fraction against cervical cancer cell was 
stated with IC50 value that indicates the amount 
of concentration producing 50% cell proliferation 
resistance. The obtained IC50 values showed that 
the ethyl acetate fraction had the lowest value at 
44.34±9.45µg/mL (Table 1). The IC50 value of an 
extract obtained under 100 µg/mL indicates their 
potential to be used as a chemopreventive agent 
(Suzery, et al., 2014). The ethyl acetate fraction 
can thus be further developed as a chemopreventive 
agent. Based on the provisions of National Cancer 
Institute, an extract declared active has anticancer 
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activity if it has a value of IC50 <30 μg/mL, moder-
ately active if 30 μg/mL ≤IC50 <100 μg/mL, and in-
active if IC50 >100 μg/mL (Rahmawati, et al., 2013). 
Based on the results, it can be seen that the ethyl ac-
etate fraction of E. palmifolia bulb is in moderately 
active category, while the n-hexane sample fraction 
and chloroform of E. palmifolia bulbs are said to 
be inactive or do not have anticancer activity. Cis-
platin is also used as a positive control with an IC50 
of 19.77 µg/mL. 
 As a result of the cytotoxic activity test the 
ethyl acetate fraction has the highest potential cyto-
toxicity. Two major compounds were obtained and 
suspected as lead compounds of anticancer activity 
of E. palmifolia bulbs. The major active compound 
with the retention time of 8.269 min is known as 
isoliquiritigenin (1). Several previous studies have 
shown that isoliquiritigenin compounds of the fla-
vonoid group have anticancer activity against B16 
melanoma cells (Iwashita, et al., 2000), colon can-
cer cells (Wang, et al., 2013), breast cancer cells 
(Hou, et al., 2017), and squamous cells (Takahashi, 
et al., 2004). Isoliquiritigenin triggered mitochon-
drial and endoplasmic reticulum stress to induced 
apoptosis in HeLa cell. The antiproliferative ac-
tivity of isoliquiritigenin against cervical cancer 
by decreased cell viability, induced cell accumu-
lation in G2/M phase and morphological and bio-
chemical features of apoptosis. Isoliquiritigenin 
was reported inhibit NF-κB activity. NF-κB is 
constitutively activated in human cancer, includ-
ing cervical cancer (Hirchaud, et al., 2013). The 
major active compound with a retention time of 
11.333 min is known to be an oxyresveratrol (2). 
Previous research proved that the derivative of 
oxyresveratrol, 3’,5’-Diacetoxy-2,4-diisopropox-
ystilbene, is selectively cytotoxic against cervi-
cal cancer HeLa cells (Chatsumpun, et al., 2016). 
CONCLUSION
 Ethyl acetate fraction has the highest bio-
activity toward HeLa cervical cancer cell line with 
IC50 of 44.34±9.45µg/mL. The identification of ac-
tive compounds showed that the major compounds 
contained in the ethyl acetate fraction of E. palmi-
folia bulbs are isoliquiritigenin and oxyresveratrol. 
The compounds were suspected to be responsible 
for the anticancer activity of E. palmifolia bulbs.
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